Page 6 of 12
What were the main results of the study?
Randomised group - double-blind phase
The main objective of the study was to compare the change in viral load in
participants who received fostemsavir with those who received placebo during the
double-blind phase.
The participantâ€™s viral load change was assessed after eight days of treatment. The
results showed that participants who received fostemsavir had a greater average
decrease in viral load after eight days of treatment compared with participants who
received placebo.
Average change in viral load after eight days of treatment
Fostemsavir Placebo
201 participants 69 participants
Average decrease in viral load 0.791 log c/mL 0.166 log c/mL
10 10
Difference 0.625 log c/mL
10